Providers often recommend a structured transition plan because both medications affect digestion, appetite, blood sugar levels, and metabolic function
People can also get it from their diet or take it in the form of an oral supplement
If the pack warms, replace it with a fresh cold source as soon as possible
In fact, people taking these drugs were 64% more likely to develop a DVT than people taking a placebo
Wegovy is a GLP-1 receptor agonist (glucagon-like peptide-1 receptor agonist) that helps treat obesity and promote weight loss by reducing appetite, slowing gastric emptying, and making you feel fuller longer
Serious gastrointestinal adverse events were uncommon but did occur, reinforcing the importance of clinical monitoring